BioSphings AG, headquartered in Frankfurt, Germany, is a privately held biotechnology company founded in 2001.

BioSphings is engaged in the discovery, development and marketing of novel pharmaceutical products to establish new standards for treating viral infections, cancer and autoimmune diseases.

BioSphings is product-driven with three drugs in development.

© BioSphings AG 2011